Maravai LifeSciences News

Investors Interested In Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Revenues

When you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3.4x, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) lo

Simply Wall StMay 11 22:50

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceMay 10 20:35

Maravai LifeSciences | 10-Q: Quarterly report

Futu NewsMay 10 04:50 · Announcements

Maravai LifeSciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed FY24 Revenue Guidance. Also, Baird Maintained an Outperform Rating on the Stock and Raised Its Price Target...

Maravai LifeSciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed FY24 Revenue Guidance. Also, Baird Maintained an Outperform

BenzingaMay 10 01:15

UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating

Maravai LifeSciences (MRVI) has an average outperform rating and price target range of $6.50 to $15, according to analysts polled by Capital IQ. Price: 9.42, Change: +0.55, Percent Change: +6.20

MT NewswiresMay 9 22:53

Maravai Lifesciences: A Strong Buy on Strategic Positioning and Operational Leverage

TipRanksMay 9 19:25

Maravai LifeSciences Is Maintained at Outperform by Baird

Maravai LifeSciences Is Maintained at Outperform by Baird

Dow JonesMay 9 18:53

Baird Maintains Outperform on Maravai LifeSciences, Raises Price Target to $10

Baird analyst Catherine Schulte maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and raises the price target from $8 to $10.

BenzingaMay 9 18:42

Earnings Call Summary | Maravai LifeSciences(MRVI.US) Q1 2024 Earnings Conference

The following is a summary of the Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript:Financial Performance:Maravai LifeSciences reported Q1 2024 revenue of $64 million, surpas

Futu NewsMay 9 16:51 · Conference Call

Analysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Arcus Biosciences (RCUS) and Maravai Lifesciences Holdings (MRVI)

TipRanksMay 9 15:30

Maravai LifeSciences Reaffirms 2024 Revenue Guidance; Sees Revenue $265M-$285M

Maravai LifeSciences Reaffirms 2024 Revenue Guidance; Sees Revenue $265M-$285M

BenzingaMay 9 05:38

Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, Vs. Street Est of $60.5M

04:44 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, vs. Street Est of $60.5M

MT NewswiresMay 9 04:44

Maravai LifeSciences Q1 2024 Adj EPS $(0.02) Beats $(0.03) Estimate, Sales $64.179M Beat $60.548M Estimate

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 166.67 percent decrease over earnings

BenzingaMay 9 04:22

Press Release: Maravai LifeSciences Reports First Quarter 2024 Financial Results

Maravai LifeSciences Reports First Quarter 2024 Financial Results Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE)

Dow JonesMay 9 04:05

Maravai LifeSciences Reports First Quarter 2024 Financial Results

Reaffirmed financial guidance for the full year 2024 including a revenue range of $265.0 million to $285.0 million..

Maravai LifeSciencesMay 9 04:05

Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)

TipRanksApr 30 20:36

TriLink BioTechnologies And Lonza Enter Into Non-exclusive License And Supply Agreement For CleanCap MRNA Capping Technology

TriLink BioTechnologies And Lonza Enter Into Non-exclusive License And Supply Agreement For CleanCap MRNA Capping Technology

BenzingaApr 30 19:38

Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego

Maravai LifeSciences Holdings' (MRVI) TriLink BioTechnologies unit said Thursday that it has opened its new, 32,000-square-foot cGMP mRNA manufacturing facility in San Diego. The facility will use Tri

MT NewswiresApr 18 21:39

Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)

TipRanksApr 18 21:00

Trilink Biotechnologies, A Maravai Lifesciences Company Opened A New 32,000 Sq.ft. MRNA Manufacturing Facility

Trilink Biotechnologies, A Maravai Lifesciences Company Opened A New 32,000 Sq.ft. MRNA Manufacturing Facility

BenzingaApr 18 19:37